CellX Biosolutions raised €159k in a funding round in Nov 2024. The company is based in Zürich, Switzerland. Investors in the round: Venture Kick. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
